All products are for laboratory research purposes only. Not for human consumption.
Synthetic dual incretin receptor agonist peptide
Tirzepatide
Tirzepatide is a synthetic 39-residue peptide that acts as a dual agonist at the GIP and GLP-1 receptors. The backbone carries a C20 diacid fatty-acid conjugate that extends its plasma half-life through albumin binding. It is supplied as a lyophilised powder in sealed vials, boxed in tens, for laboratory research use only.
$80.00 (£63.20) per box of 10 vials · 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 100 mg, 120 mg
Overview
What is Tirzepatide?
Tirzepatide is a synthetic 39-residue peptide that acts as a dual agonist at the GIP and GLP-1 receptors. The backbone carries a C20 diacid fatty-acid conjugate that extends its plasma half-life through albumin binding. It is supplied as a lyophilised powder in sealed vials, boxed in tens, for laboratory research use only.
Tirzepatide at a glance
| Compound | Tirzepatide |
|---|---|
| Also known as | LY3298176, dual agonist peptide, tirzepatide acetate |
| Classification | Synthetic dual incretin receptor agonist peptide |
| CAS number | 2023788-19-2 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.45 g/mol |
| Sequence | 39-residue backbone with a C20 diacid fatty-acid conjugate |
| Purity | 99%+ by HPLC |
| Physical form | Lyophilised powder |
| Available strengths | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 100 mg, 120 mg |
| Box quantity | 10 vials |
| Price from | $8.00 per vial ($80.00 per box) |
| Research status | An approved prescription medicine in the UK and elsewhere. Supply outside the regulated pharmaceutical chain is unlawful. Included here strictly as a laboratory reference material. |
| Documentation | Batch-specific COA (Janoshik or Freedom Diagnostic) |
Nominal specifications. The authoritative figures for any given box are those printed on its batch COA.
Pricing
How much does Tirzepatide cost?
Tirzepatide starts at $8.00 per vial (£6.32), sold in boxes of 10 at $80.00. One box is the smallest order and there is no trade account or minimum spend. Larger volumes are negotiable.
| Strength | Per vial | Box of 10 |
|---|---|---|
| 10 mg | $8.00 £6.32 | $80.00 £63.20 |
| 15 mg | $9.09 £7.18 | $90.85 £71.77 |
| 20 mg | $9.83 £7.77 | $98.28 £77.64 |
| 30 mg | $11.69 £9.24 | $116.85 £92.31 |
| 40 mg | $13.17 £10.40 | $131.71 £104.05 |
| 50 mg | $15.40 £12.17 | $154.00 £121.66 |
| 60 mg | $16.33 £12.90 | $163.28 £128.99 |
| 100 mg | $23.39 £18.48 | $233.85 £184.74 |
| 120 mg | $25.43 £20.09 | $254.28 £200.88 |
Handling
How should Tirzepatide be stored and reconstituted?
Full explanation of why each of these matters: peptide handling and storage reference.
Research Context
What is Tirzepatide researched for?
Below is a plain-English summary of what published research has investigated, and what it has found. These are descriptions of research activity and published results. They are not claims about what Tirzepatide does, and nothing here is a statement that it is safe or effective for any purpose.
Dual receptor activation
Tirzepatide activates both the GIP and GLP-1 receptors from one molecule. It is not a balanced agonist: it is considerably more potent at GIP, and how that imbalance contributes to the overall effect is still an open research question. 1
The role of GIP
GIP is the interesting part. On its own it does little for body weight, yet combined with GLP-1 activation the effect appears larger than GLP-1 alone. Working out why is an active area of incretin research.
References
- 1Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med (2022). PMID 35658024
- 2Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med (2025). PMID 39536238
Links open the record on PubMed or PubMed Central. These are citations to published research, not claims about this product.
Compare Tirzepatide
Applications
Where Tirzepatide is used in the laboratory
- Dual incretin receptor pharmacology and comparative binding studies
- Receptor selectivity profiling against single-agonist reference compounds
- Fatty-acylated peptide stability and formulation research
- Analytical characterisation of long-acting incretin analogues
Verification
Does Tirzepatide come with a COA?
Yes — every box. Each batch of Tirzepatide is analysed by Janoshik Analytical or Freedom Diagnostic. The certificate confirms identity by mass spectrometry and purity by HPLC, and is tied to the batch number printed on the vial label. You can ask to see it before you order.
Example COA. You receive the certificate matching your own batch.
Questions
Tirzepatide questions, answered
How does tirzepatide differ from retatrutide?
Both are long-acting incretin agonists built on a similar acylated peptide scaffold. Tirzepatide is a dual agonist, binding the GIP and GLP-1 receptors. Retatrutide is a triple agonist, adding activity at the glucagon receptor. In receptor-selectivity work the two are frequently run side by side for exactly that reason.
How much does Tirzepatide cost?
Tirzepatide starts at $8.00 per vial, sold in boxes of 10 vials at $80.00 per box (about £63.20). 9 strengths available: 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 100 mg, 120 mg. There is no minimum order.
What purity is your Tirzepatide?
All batches test at 99%+ purity. Every box ships with a batch-specific Certificate of Analysis from Janoshik Analytical or Freedom Diagnostic, confirming identity by mass spectrometry and purity by HPLC.
Is there a minimum order for Tirzepatide?
No. You can order a single box of 10 vials. There is no trade account, bulk commitment or minimum spend.
How is Tirzepatide shipped?
Tracked and in discreet, plain packaging, dispatched within 1–3 working days. Delivery estimates are UK 5–7 working days, EU 8–10, USA 5–8 and rest of world 10–12. Full detail is on the shipping page.
